Retinal Biologics Market Report

Global and Region Retinal Biologics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：209
  • REPORT CODE：GMM880676
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Retinal Biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Biologicsmarket, defines the market attractiveness level of Retinal Biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Retinal Biologics industry, describes the types of Retinal Biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Biologics market and the development prospects and opportunities of Retinal Biologics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Biologics market in Chapter 13.

    By Player:

    • F Hoffmann-La Roche Ltd

    • Johnson and Johnson Services Inc

    • Amgen Inc

    • Regeneron Pharmaceuticals, Inc

    • Spark Therapeutics, Inc

    • AbbVie Inc

    By Type:

    • Macular Degeneration

    • Diabetic Retinopathy

    • Diabetic Macular Edema

    • Uveitis

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Retinal Biologics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Retinal Biologics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Retinal Biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Retinal Biologics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Retinal Biologics Market Analysis and Outlook to 2022

    • 7.1 Global Retinal Biologics Consumption (2017-2022)

    • 7.2 United States Retinal Biologics Consumption (2017-2022)

    • 7.3 Europe Retinal Biologics Consumption (2017-2022)

    • 7.4 China Retinal Biologics Consumption (2017-2022)

    • 7.5 Japan Retinal Biologics Consumption (2017-2022)

    • 7.6 India Retinal Biologics Consumption (2017-2022)

    • 7.7 South Korea Retinal Biologics Consumption (2017-2022)

    8 Region and Country-wise Retinal Biologics Market Analysis and Outlook to 2028

    • 8.1 Global Retinal Biologics Consumption Forecast (2022-2028)

    • 8.2 United States Retinal Biologics Consumption Forecast (2022-2028)

    • 8.3 Europe Retinal Biologics Consumption Forecast (2022-2028)

    • 8.4 China Retinal Biologics Consumption Forecast (2022-2028)

    • 8.5 Japan Retinal Biologics Consumption Forecast (2022-2028)

    • 8.6 India Retinal Biologics Consumption Forecast (2022-2028)

    • 8.7 South Korea Retinal Biologics Consumption Forecast (2022-2028)

    9 Global Retinal Biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Retinal Biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Macular Degeneration Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Diabetic Macular Edema Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Uveitis Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Retinal Biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Retinal Biologics Market Outlook by Types and Applications to 2028

    • 10.1 Global Retinal Biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Diabetic Macular Edema Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Uveitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Retinal Biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Retinal Biologics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Retinal Biologics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Retinal Biologics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Retinal Biologics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Retinal Biologics Market Competitive Analysis

    • 14.1 F Hoffmann-La Roche Ltd

      • 14.1.1 F Hoffmann-La Roche Ltd Company Details

      • 14.1.2 F Hoffmann-La Roche Ltd Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 F Hoffmann-La Roche Ltd Retinal Biologics Product and Service

    • 14.2 Johnson and Johnson Services Inc

      • 14.2.1 Johnson and Johnson Services Inc Company Details

      • 14.2.2 Johnson and Johnson Services Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson and Johnson Services Inc Retinal Biologics Product and Service

    • 14.3 Amgen Inc

      • 14.3.1 Amgen Inc Company Details

      • 14.3.2 Amgen Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen Inc Retinal Biologics Product and Service

    • 14.4 Regeneron Pharmaceuticals, Inc

      • 14.4.1 Regeneron Pharmaceuticals, Inc Company Details

      • 14.4.2 Regeneron Pharmaceuticals, Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Product and Service

    • 14.5 Spark Therapeutics, Inc

      • 14.5.1 Spark Therapeutics, Inc Company Details

      • 14.5.2 Spark Therapeutics, Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Spark Therapeutics, Inc Retinal Biologics Product and Service

    • 14.6 AbbVie Inc

      • 14.6.1 AbbVie Inc Company Details

      • 14.6.2 AbbVie Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie Inc Retinal Biologics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Retinal Biologics

    • Figure Retinal Biologics Picture

    • Table Global Retinal Biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Biologics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Retinal Biologics Consumption by Country (2017-2022)

    • Figure United States Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Figure China Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Figure India Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Retinal Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Retinal Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Macular Degeneration Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Macular Edema Consumption and Growth Rate (2017-2022)

    • Figure Global Uveitis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetic Macular Edema Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Uveitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Retinal Biologics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Retinal Biologics Export by Region (Top 5 Countries) (2017-2028)

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Retinal Biologics Product and Service

    • Table Johnson and Johnson Services Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Services Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Services Inc Retinal Biologics Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Retinal Biologics Product and Service

    • Table Regeneron Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals, Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals, Inc Retinal Biologics Product and Service

    • Table Spark Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Spark Therapeutics, Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spark Therapeutics, Inc Retinal Biologics Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Retinal Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Retinal Biologics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US